Volume 15/Issue 4, July 2019
The changing picture of neonatal abstinence syndrome: ‘new drugs on
Rachel Toone, Kathryn Johnson, Cath Harrison
Neonatal abstinence syndrome (NAS) is usually associated with maternal opioid use but the pattern of drug use is changing, with many affected infants now having been exposed to new psychoactive substances in utero. This article will focus on emerging recreational substances, particularly synthetic cannabinoids, the challenges faced in the management of NAS in these cases, and the potential long-term consequences.
Toone R., Johnson K., Harrison C. The changing picture of neonatal abstinence syndrome: ‘new drugs on the block’. Infant 2019;15(4): 138-40.
Abbreviated: Please subscribe and log in to see the full article.